The Endocrine Society now issued a Clinical Practice Guideline (CPG) advising against the use of testosterone therapy in healthy women. Although the FDA approved testosterone therapy for the treatment of disorders involving the testes, pituitary and hypothalamus, it hasn't been approved for treating age-related declines in testosterone levels. The U.S. National Institute on Aging is also expected to release the results of research on the security of testosterone. The study included approximately 800 older men with low testosterone and symptoms related to this illness, for example http://tinyurl.com/zj86oxg
sexual and physical dysfunction. The research is anticipated to shed more light on the security of testosterone treatment since the heart health of the men was carefully monitored.
The recent contradictory findings on testosterone therapy prompted his team to run a sizeable systematic
literature search for studies assessing the relationship between testosterone replacement therapy and cardiovascular events among guys and Patel. An estimated 13 million men in the United States have problems with low testosterone, which occurs when the body does not make enough hormones as a result of a problem with the testicles or pituitary gland. This describes loss of energy, apparent aging and a person's sudden weight gain.
And many girls have a knee jerk suspicion that any hormone treatment
can increase their risk of breast cancer. However, clinical studies demonstrate that testosterone not only does not increase a woman's risk of breast cancer , it may play a key role in warding off the disease. Glaser thinks this will probably remain the status quo for some time, given the prohibitive cost of running the long term safety studies needed to acquire fuller FDA acceptance.